Position in KURA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$852,145
-$233,059 QoQ
Shares Held
104,815
+0.4% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 17.762724800839575.ToString("F0")%
Shared 0.ToString("F0")%
None 82.23727519916042.ToString("F0")%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. KURA ranks #128 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in KURA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $852,145 | 104,815 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,085,204 | 104,447 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,061,424 | 119,935 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $686,029 | 118,896 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $694,359 | 105,206 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $870,921 | 99,991 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,916,248 | 98,068 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,144,983 | 104,176 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,423,258 | 113,608 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,611,465 | 112,063 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,011,189 | 110,876 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,117,417 | 105,616 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,271,956 | 104,003 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,249,724 | 100,703 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,343,105 | 98,324 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,678,863 | 91,591 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,342,438 | 83,485 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,268,624 | 90,616 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,718,290 | 91,740 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,852,314 | 88,840 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,910,825 | 67,592 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,289,139 | 70,090 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,930,289 | 62,999 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,163,151 | 71,359 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $422,685 | 42,481 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||